Pharmaceutical Manufacturer
Shire US Inc.Find BBB Accredited Businesses in Pharmaceutical Manufacturer.
About
Important information
- Pending Government Action:Government Action: BBB reports on known government actions involving business’ marketplace conduct:Federal Trade Commission vs. Shire ViroPharma, Inc.
The following describes a pending government action that has been formally brought by a government agency but has not yet been resolved. We are providing a summary of the governments allegations, which have not yet been proven.
On 2/7/2017 the Federal Trade Commission (FTC) announced a complaint had been filed in federal district court charging Shire ViroPharma Inc. (“ViroPharma”) with violating the antitrust laws by abusing government processes to delay generic competition to its branded prescription drug, Vancocin HCl Capsules. The complaint alleges that because of ViroPharma’s actions, consumers and other purchasers paid hundreds of millions of dollars more for their medication.
The FTC alleges that to maintain its monopoly, ViroPharma waged a campaign of serial, repetitive, and unsupported filings with the U.S. Food and Drug Administration and courts to delay the FDA’s approval of generic Vancocin Capsules, and exclude competition. According to the FTC, ViroPharma submitted 43 filings with the FDA and filed three lawsuits against the FDA between 2006 and 2012. The number and frequency of ViroPharma’s petitioning at the FDA are many multiples beyond that by any drug company related to any other drug. ViroPharma knew that it was the FDA’s practice to refrain from approving any generic applications until it resolved any pending relevant citizen petition filings. Viropharma intended for its serial filings to delay the approval of generics, and thus competition and lower prices.
Business Details
- BBB File Opened:
- 11/6/2006
- Business Started:
- 9/28/1983
- Business Incorporated:
- 9/28/1983
- Type of Entity:
- Corporation
- Alternate Names:
- ViroPharma
- Business Management:
- Mr. Delroy Heath, Owner
- Mr. Flemming Ornskov MD, CEO
- Mr. Bill Mordan Esquire, General Counsel
- Mr. Jeffrey Poulton, CFO
- Number of Employees:
- 1
Additional Contact Information
- Principal Contacts
- Mr. Delroy Heath, Owner
- Mr. Flemming Ornskov MD, CEO
- Mr. Bill Mordan Esquire, General Counsel
- Mr. Jeffrey Poulton, CFO
Additional Information
- Referral Assistance
- Massachusetts Controlled Substances Registration
239 Causeway Street
Boston MA 02114
Phone Number: 617-973-0949
Fax Number: 617-753-8233
https://www.mass.gov/orgs/massachusetts-controlled-substances-registration
MCSR@Massmail.State.MA.US - Business Categories
- Pharmaceutical Manufacturer
More Resources
Featured Content
BBB Business Profiles may not be reproduced for sales or promotional purposes.
BBB Business Profiles are provided solely to assist you in exercising your own best judgment. BBB asks third parties who publish complaints, reviews and/or responses on this website to affirm that the information provided is accurate. However, BBB does not verify the accuracy of information provided by third parties, and does not guarantee the accuracy of any information in Business Profiles.
When considering complaint information, please take into account the company's size and volume of transactions, and understand that the nature of complaints and a firm's responses to them are often more important than the number of complaints.
BBB Business Profiles generally cover a three-year reporting period. BBB Business Profiles are subject to change at any time. If you choose to do business with this business, please let the business know that you contacted BBB for a BBB Business Profile.
As a matter of policy, BBB does not endorse any product, service or business. Businesses are under no obligation to seek BBB accreditation, and some businesses are not accredited because they have not sought BBB accreditation. BBB charges a fee for BBB Accreditation. This fee supports BBB's efforts to fulfill its mission of advancing marketplace trust.